“Our customers are increasingly demanding even greater quality and verification to meet their demanding applications and the latest standards,” explained Jonas Forslund, production engineer at Bumax. “In response, we have invested in our in-house capabilities in the form of new equipment and competence.”
“At Bumax, we sell high-quality products and it’s essential that we remain relevant in the market by continuing to be able to meet the highest demands of our customers,” explains Jonas Nilsson-Öst, quality manager at Bumax. “This goes beyond our products to offer services and testing capabilities that enable the customer to fine-tune and further improve their fastener applications.”
120-tonne and 25-tonne tensile testing machines
Some of the new equipment has already improved quality for all Bumax batches, such as 120-tonne and 25-tonne tensile testing machines, which are used to determine the strength and deformation behaviour of fasteners from every batch before it leaves the Bumax factory. A new optical measuring machine accurately measures the dimensions of fasteners, including anomalies up to 0.0001 mm, which is about a thousandth of what is visible with the naked eye. Additionally, the new microsamples lab line is a key addition to enhance the quality testing capabilities of the Bumax R&D lab.
An important part of the investment is data consolidation software that combines datapoints from multiple machines and sources, which provides deep insight into material and manufacturing quality. The investment also includes a microsamples lab line, a micro hardness machine and a magnetic permeability measuring tool.
“Our new capabilities can support future product development, such as by verifying a new stainless steel material or production capabilities,” concluded Forslund. “In addition to our new equipment, we’ve employed an additional person to work with testing and have trained our existing technicians on the latest techniques and standards. These investments in our personnel are just as important as our equipment investments.”
